Research summary, guideline or consensus statement, 2012

CRP Statement on Tissue Reactions / Early and Late Effects of Radiation in Normal Tissues and Organs, Threshold Doses for Tissue Reactions in a Radiation Protection Context

2012

Open the source page

In plain language

This International Commission on Radiological Protection (ICRP) review lowered the practical threshold for cataract to about 0.5 Gy and proposed a similar, uncertain threshold for circulatory disease, regardless of dose rate. This matters for the cumulative dose of fluoroscopy teams over a working life.

At a glance

Type of study
Guideline or consensus statement
Who was studied
General population
Summary based on
a web page

What it found

  • The threshold dose for radiation-induced cataract is now considered approximately 0.5 Gy for acute and fractionated exposures, about ten times lower than earlier estimates.

    Key figures: approximately 0.5 Gy; lower by a factor of 10

  • Circulatory disease is recognised as a late radiation effect, with a proposed threshold of about 0.5 Gy to the heart and cerebrovascular system, leading to about 1% incidence more than 10 years after exposure; estimates are uncertain.

    Key figures: 0.5 Gy; ~1% incidence >10 years

  • Doses of 0.5 Gy to the heart and cerebrovascular system could be reached in some complex interventional procedures, so practitioners should emphasise optimisation.

    Key figures: 0.5 Gy

  • For cataracts and circulatory disease, dose rate does not appear to modify incidence, so the same ~0.5 Gy threshold is applied to acute, fractionated and chronic exposure over a working life.

    Key figures: 0.5 Gy irrespective of dose rate

  • There are no established mitigators of radiation lens injury; some biological response modifiers give modest dose modification in other tissues.

    Key figures: DMFs 1.1-1.2, in a few cases 1.5-2

Limits to keep in mind

A consensus review drawing mainly on atomic bomb survivors, radiotherapy and accident data rather than fluoroscopy staff; the report itself notes notable uncertainty in risk estimates at around 0.5 Gy, particularly for circulatory disease.

How this summary was made

ORSIF prepared this summary with AI assistance from a web page of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.